| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.0062 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |